Patent details

EP2240578 Title: SUBSTANTIALLY ANIMAL PROTEIN-FREE RECOMBINANT FURIN AND METHODS FOR PRODUCING SAME

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP2240578
WO Application Number:
US2008087732
Type:
European Patent Granted for NL
Status:
Patent in Force
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP08869658.8
WO Publication Number:
WO2009088713
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
Switzerland (CH)
Publications:

Dates

Filing date:
19/12/2008
Grant date:
20/03/2019
EP Publication Date:
20/10/2010
WO Publication Date:
16/07/2009
Claims Translations Received Date:
Claims Translation B1 Received Date:
07/06/2019
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
20/03/2019
EP B1 Publication Date:
20/03/2019
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
18/12/2028
Lapsed By Expiration Date:
Patent Validated Date:
27/06/2019
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
22/12/2021
 
 

 

Name:
Takeda Pharmaceutical Company Limited
Address:
1-1, Doshomachi 4-chome, Chuo-ku, Osaka-shi, Osaka, Japan (JP)

Historical Applicant/holder

From:
22/12/2021
To:
22/12/2021

 

Name:
Baxalta GmbH
Address:
Thurgauerstrasse 130 Glattpark (Opfikon), 8152, Zürich, Switzerland (CH)

From:
20/03/2019
To:
22/12/2021

 

Name:
Baxalta GmbH
Address:
Zählerweg 4, 6300 Zug, Switzerland (CH)

From:
20/03/2019
To:
22/12/2021

 

Name:
Baxalta Incorporated
Address:
1200 Lakeside Drive, 60015, Bannockburn, Illinois, United States of America (US)

Agent

Name:
mr.ir. F.N. Ferro
From:
26/06/2019
Address:
Hoffmann Eitle B.V. Strawinskylaan 3051 4th Floor, 1077 ZX, AMSTERDAM, Netherlands (NL)
To:

Inventor

1

Name:
PLAIMAUER, Barbara
Address:
A-1020 Vienna, Austria (AT)

2

Name:
VON FIRCKS, Simone
Address:
2012 Auckland, New Zealand (NZ)

3

Name:
GRILLBERGER, Leopold
Address:
A-1220 Vienna, Austria (AT)

4

Name:
HASSLACHER, Meinhard
Address:
A-1020 Vienna, Austria (AT)

5

Name:
GEYER, Roland
Address:
A-1200 Vienna, Austria (AT)

6

Name:
MITTERER, Artur
Address:
A-2304 Orth/donau, Austria (AT)

7

Name:
REITER, Manfred
Address:
A-1150 Vienna, Austria (AT)

Priority

Priority Patent Number:
1815207 P
Priority Date:
31/12/2007
Priority Country:
United States of America (US)

Classification

IPC or IDT classification:
C07K 14/755; C12N 9/64; C12P 21/02;

Publication

Bulletin

1

Bulletin Heading:
CO
Journal edition number:
05/22
Publication date:
02/02/2022
Description:
Changes in the Netherlands Patent Register

2

Bulletin Heading:
EP3
Journal edition number:
27/19
Publication date:
03/07/2019
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

3

Bulletin Heading:
EP2
Journal edition number:
12/19
Publication date:
20/03/2019
Description:
European patents granted for the Netherlands

European Patent Bulletin

1

Issue number:
201917
Publication date:
24/04/2019
Description:
Application number/publication number of the divisional application (Art. 76) changed

2

Issue number:
201912
Publication date:
20/03/2019
Description:
Grant (B1)

Deed

Change of Address

Change Kind/ Decision Type:
Owner
Deed Number:
RC202102720A
Date Registered:
22/12/2021
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
Baker & McKenzie Amsterdam N.V.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Change of owner(s)

Change Kind/ Decision Type:
Assignment
Deed Number:
RC202102720B
Date Registered:
22/12/2021
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
Baker & McKenzie Amsterdam N.V.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

Name:
Takeda Pharmaceutical Company Limited
Address:
1-1, Doshomachi 4-chome, Chuo-ku, Osaka-shi, Osaka, Japan (JP)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Annual Fee

Annual Fee(s) Due Date:
31/12/2025
Annual Fee Number:
18
Annual Fee Amount:
1200 Euro
Last Annual Payment Date:
21/11/2024
Last Annual Fee Paid Number:
17
Last Annual Fee Paid Amount:
1100 Euro
Payer:
Anaqua Services
Filing date Document type Document Description Number of pages File Type
26/06/2019 Outgoing Correspondence Letter no formal defects 1 PDF /7/6/1/6/8/0800386167/docs/ep08869658.8_1_282582l271.pdf
07/06/2019 Claims First filed claims 2 PDF /7/6/1/6/8/0800386167/docs/ep08869658.8_0_claims20190607164836136.pdf